These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34039638)

  • 21. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
    Srivastava N; Sudan R; Saha B
    J Immunol; 2011 May; 186(10):5863-72. PubMed ID: 21471446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.
    Shen J; Chandrasekharan UM; Ashraf MZ; Long E; Morton RE; Liu Y; Smith JD; DiCorleto PE
    Circ Res; 2010 Mar; 106(5):902-10. PubMed ID: 20093631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses.
    Salojin KV; Owusu IB; Millerchip KA; Potter M; Platt KA; Oravecz T
    J Immunol; 2006 Feb; 176(3):1899-907. PubMed ID: 16424221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration.
    Kinney CM; Chandrasekharan UM; Mavrakis L; DiCorleto PE
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C241-50. PubMed ID: 18003751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice.
    Roth RJ; Le AM; Zhang L; Kahn M; Samuel VT; Shulman GI; Bennett AM
    J Clin Invest; 2009 Dec; 119(12):3817-29. PubMed ID: 19920356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of MKP-1 regulation of p38 to endotoxin tolerance.
    Nimah M; Zhao B; Denenberg AG; Bueno O; Molkentin J; Wong HR; Shanley TP
    Shock; 2005 Jan; 23(1):80-7. PubMed ID: 15614136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.
    Dauletbaev N; Eklove D; Mawji N; Iskandar M; Di Marco S; Gallouzi IE; Lands LC
    J Biol Chem; 2011 May; 286(18):15998-6007. PubMed ID: 21454676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells.
    Turpeinen T; Nieminen R; Moilanen E; Korhonen R
    J Pharmacol Exp Ther; 2010 Apr; 333(1):310-8. PubMed ID: 20089808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of interleukin-12 is increased by MAP kinase phosphatase-1 through a mechanism related to interferon regulatory factor 1.
    Korhonen R; Huotari N; Hömmö T; Leppänen T; Moilanen E
    Mol Immunol; 2012 Jun; 51(2):219-26. PubMed ID: 22464096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in subcellular localization of p38 MAPK potentiates endothelin-stimulated COX-2 expression in glomerular mesangial cells.
    Pratt PF; Bokemeyer D; Foschi M; Sorokin A; Dunn MJ
    J Biol Chem; 2003 Dec; 278(51):51928-36. PubMed ID: 14530261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1.
    Yu H; Sun Y; Haycraft C; Palanisamy V; Kirkwood KL
    Cytokine; 2011 Nov; 56(2):245-55. PubMed ID: 21733716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide.
    Thomas KE; Galligan CL; Newman RD; Fish EN; Vogel SN
    J Biol Chem; 2006 Oct; 281(41):31119-30. PubMed ID: 16912041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal regulation of cytokine mRNA expression by tristetraprolin: dynamic control by p38 MAPK and MKP-1.
    Prabhala P; Bunge K; Rahman MM; Ge Q; Clark AR; Ammit AJ
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L973-80. PubMed ID: 25724669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia.
    Jeyaseelan S; Young SK; Fessler MB; Liu Y; Malcolm KC; Yamamoto M; Akira S; Worthen GS
    J Immunol; 2007 Mar; 178(5):3153-60. PubMed ID: 17312163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells.
    Rastogi R; Du W; Ju D; Pirockinaite G; Liu Y; Nunez G; Samavati L
    Am J Respir Crit Care Med; 2011 Feb; 183(4):500-10. PubMed ID: 20851927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1.
    Valente AJ; Yoshida T; Gardner JD; Somanna N; Delafontaine P; Chandrasekar B
    Cell Signal; 2012 Feb; 24(2):560-568. PubMed ID: 22037550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of tristetraprolin expression by mitogen-activated protein kinase phosphatase-1.
    Huotari N; Hömmö T; Taimi V; Nieminen R; Moilanen E; Korhonen R
    APMIS; 2012 Dec; 120(12):988-99. PubMed ID: 23030431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obacunone causes sustained expression of MKP-1 thus inactivating p38 MAPK to suppress pro-inflammatory mediators through intracellular MIF.
    Gao Y; Hou R; Liu F; Liu H; Fei Q; Han Y; Cai R; Peng C; Qi Y
    J Cell Biochem; 2018 Jan; 119(1):837-849. PubMed ID: 28657665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.
    Kim SJ; Baek KS; Park HJ; Jung YH; Lee SM
    Br J Pharmacol; 2016 Mar; 173(6):1045-57. PubMed ID: 26689981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.